Buffon A - Search Results

1

Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma.

Venturini CG, Bruinsmann FA, Contri RV, Fonseca FN, Frank LA, D'Amore CM, Raffin RP, Buffon A, Pohlmann AR, Guterres SS. Venturini CG, et al. Among authors: buffon a. Eur J Pharm Sci. 2015 Nov 15;79:36-43. doi: 10.1016/j.ejps.2015.08.016. Epub 2015 Sep 3. Eur J Pharm Sci. 2015. PMID: 26342772

2

Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.

Fontana MC, Beckenkamp A, Buffon A, Beck RC. Fontana MC, et al. Among authors: buffon a. Int J Nanomedicine. 2014 Jun 17;9:2979-91. doi: 10.2147/IJN.S62857. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24971009 Free PMC article.

3

Pharmacokinetic/pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker-256 tumor-bearing rat model using free intratumoral drug concentrations.

Pigatto MC, Roman RM, Carrara L, Buffon A, Magni P, Dalla Costa T. Pigatto MC, et al. Among authors: buffon a. Eur J Pharm Sci. 2017 Jan 15;97:70-78. doi: 10.1016/j.ejps.2016.10.038. Epub 2016 Nov 2. Eur J Pharm Sci. 2017. PMID: 27816627

4

Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).

Oliveira CP, Prado WA, Lavayen V, Büttenbender SL, Beckenkamp A, Martins BS, Lüdtke DS, Campo LF, Rodembusch FS, Buffon A, Pessoa A Jr, Guterres SS, Pohlmann AR. Oliveira CP, et al. Among authors: buffon a. Pharm Res. 2017 Feb;34(2):438-452. doi: 10.1007/s11095-016-2074-2. Epub 2016 Dec 15. Pharm Res. 2017. PMID: 27981451

5

The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: Increasing penetration and adhesion of imiquimod in vaginal tissue.

Frank LA, Chaves PS, D'Amore CM, Contri RV, Frank AG, Beck RC, Pohlmann AR, Buffon A, Guterres SS. Frank LA, et al. Among authors: buffon a. Eur J Pharm Biopharm. 2017 May;114:202-212. doi: 10.1016/j.ejpb.2017.01.021. Epub 2017 Feb 1. Eur J Pharm Biopharm. 2017. PMID: 28161547

6

Liquid formulation containing doxorubicin-loaded lipid-core nanocapsules: Cytotoxicity in human breast cancer cell line and in vitro uptake mechanism.

Antonow MB, Asbahr ACC, Raddatz P, Beckenkamp A, Buffon A, Guterres SS, Pohlmann AR. Antonow MB, et al. Among authors: buffon a. Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:374-382. doi: 10.1016/j.msec.2017.03.099. Epub 2017 Mar 14. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28482541

7

Doxazosin nanoencapsulation improves its in vitro antiproliferative and anticlonogenic effects on breast cancer cells.

Krai J, Beckenkamp A, Gaelzer MM, Pohlmann AR, Guterres SS, Filippi-Chiela EC, Salbego C, Buffon A, Beck RCR. Krai J, et al. Among authors: buffon a. Biomed Pharmacother. 2017 Oct;94:10-20. doi: 10.1016/j.biopha.2017.07.048. Epub 2017 Jul 24. Biomed Pharmacother. 2017. PMID: 28750355

8

Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells.

Antonow MB, Franco C, Prado W, Beckenkamp A, Silveira GP, Buffon A, Guterres SS, Pohlmann AR. Antonow MB, et al. Among authors: buffon a. Nanomaterials (Basel). 2017 Dec 22;8(1):2. doi: 10.3390/nano8010002. Nanomaterials (Basel). 2017. PMID: 29271920 Free PMC article.

9

Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7).

de Oliveira CP, Büttenbender SL, Prado WA, Beckenkamp A, Asbahr AC, Buffon A, Guterres SS, Pohlmann AR. de Oliveira CP, et al. Among authors: buffon a. Nanomaterials (Basel). 2018 Jan 4;8(1):24. doi: 10.3390/nano8010024. Nanomaterials (Basel). 2018. PMID: 29300349 Free PMC article.

10

Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line.

Frank LA, Gazzi RP, de Andrade Mello P, Buffon A, Pohlmann AR, Guterres SS. Frank LA, et al. Among authors: buffon a. Eur J Pharm Biopharm. 2019 Mar;136:9-17. doi: 10.1016/j.ejpb.2019.01.001. Epub 2019 Jan 7. Eur J Pharm Biopharm. 2019. PMID: 30630060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters